Home health agency valuation with a supported payment model

Define the agency and the payment population

Begin with the legal interest, locations and business lines included in the valuation. List the Medicare fee-for-service, Medicare Advantage and other payer work actually present. The same company may earn revenue under several payment arrangements, so one national update cannot be applied to all receipts.

The home-health overview explains the operating model. For valuation, ask which services and payment periods support each earnings figure. Keep the measurement date and the period being modeled visible. A recent month of cash collections may include claims from several earlier service periods.

IRS guidance tells its appraisers to identify the interest, date and assumptions and match the benefit stream to the valuation method. (Source: IRS valuation guidance) That is scoped internal guidance, not an agency sale-price dataset. The reviewer must still explain why the chosen method fits this transaction.

Read the payment update as one part of the model

CMS describes home-health PPS payment using 30-day periods, case-mix and wage adjustments, with per-visit payment for periods below the applicable threshold. (Source: CMS Home Health PPS) The PDGM definition provides the basic terms. None supplies the target's net payment for every period.

Have a qualified payment reviewer identify the inputs that changed and the service population affected. Preserve other assumptions while isolating that effect. Then reconcile the result with recorded claims and payments. If case mix, geography and patient volume all change at once, the difference cannot be described simply as a rate update.

The CY 2026 final-rule fact sheet distinguishes the routine update from permanent, temporary and outlier effects. (Source: CMS 2026 final rule) A favorable component can coexist with a different aggregate result. Neither figure is the agency's earnings forecast.

Separate provider adjustments from new cost assumptions

Expanded HHVBP applies a provider-specific adjustment to relevant Medicare fee-for-service payments, based on the model's performance and payment-year framework. (Source: CMS expanded HHVBP) Obtain the agency's actual report. Do not use a public star rating or the maximum possible adjustment as a substitute.

Check whether the starting payment figure already includes that adjustment. Record the treatment in the model so a later step does not apply it again. A workbook with several separate tabs can repeat an adjustment even when each tab looks reasonable by itself.

Next, identify the costs required for the modeled work. Separate wage or vendor price changes from staffing levels, vacancies and changes in service needs. The reviewer should be able to explain both the payment effect and the cost effect without treating every difference as a result of Medicare policy.

Worked example: higher modeled payment, lower contribution

Consider a fictional fixed service population reviewed under two sets of assumptions. Its baseline eligible payment is $160,000, with no provider adjustment in that baseline. A separate hypothetical recalculation adds $4,800 before a fictional minus 1% provider adjustment. The example assumes that adjustment applies to the entire recalculated amount.

The revised payment is $164,800 × 0.99 = $163,152. Its contribution is $163,152 − $148,700 = $14,452, which is $3,548 below the baseline. The payment increase did not offset the stated cost increase.

These are invented inputs, not CMS rates or an agency reimbursement estimate. The recalculation is assumed complete for its stated population; the table does not perform coding, wage-index or outlier calculations. Defined costs include all operating costs assumed here, including necessary owner replacement. Financing, tax, capital spending, cash timing and other payer populations are excluded. No individual care decision or value conclusion follows.

Test the cost base against the care being provided

Financial analysis should reflect the work the agency must perform. Section 484.60 requires individualized care planning and coordinated services within the Medicare HHA framework. (Source: 42 CFR 484.60) A lower visit budget does not by itself support an appropriate change to care.

Ask the clinical and operating reviewers to explain the resources behind the model. Include coordination, travel, documentation and supervision where performed. Identify tasks handled by shared corporate staff or the owner. If those resources will stop, show the replacement plan and its cost.

Compare payroll, contractor invoices and other support with the period used in the valuation. IRS guidance describes source records supporting book entries. (Source: IRS supporting records) It does not determine the correct care plan or approve an add-back. Those conclusions require their own evidence and qualified review.

Keep future policy scenarios separate from current results

As of September 8, 2026, CMS's July 1 fact sheet describes a proposed CY 2027 home-health rule. (Source: CMS 2027 proposed rule) Its proposals should not be labeled final payment policy. Identify their potential effect in a separate scenario, with the date and assumptions shown.

That scenario can be useful without being certain. Ask the reviewer to explain how the valuation handles an unresolved future change and what later evidence would require an update. Avoid quietly replacing current rates with proposed rates in one tab while leaving the report's date and explanation unchanged.

Keep operational proposals separate too. New branches, added staff or different payer contracts may need resources and approvals before they produce revenue. Show the existing business's supported earnings alongside those plans. This helps the buyer see how much of the proposed value depends on work still to be completed.

Select a comparison that uses the same earnings basis

Review the earnings-measure guide before discussing a multiple. Specify whether the analysis uses historical adjusted earnings, a future benefit stream or another measure. Explain whether the payment assumptions reflect the valuation date and which costs remain inside the result.

The home-health multiple guide asks whether a quote uses past earnings or a forecast. Its fictional case keeps the price fixed. The ratio falls when the buyer assumes higher earnings; no price cut occurs.

For a proposed comparable sale, request more than a headline price. Examine its date, service mix, size, payment population, earnings period and transaction terms. A larger platform may have different corporate costs and opportunities from a small agency. A disclosed price without those details does not establish a reliable benchmark.

Ask the reviewer to show why the comparison is relevant and how limitations affect its weight. If suitable evidence is unavailable, say so. A precise-looking multiple cannot repair an uncertain earnings base. No unverified national range or claimed premium for Medicare participation is supplied on this page.

Reconcile value with balances and transaction feasibility

The AR review addresses collection evidence for amounts already recorded. A valuation earnings measure does not tell you which old balances pass to the buyer or when those balances become cash. Keep that allocation and the early operating funding plan clear in the transaction terms.

The license-value buyer review tests a separate price question. Its fictional offer already assumes the intended operating position, yet the seller requests another amount for license value. Identify the added benefit before changing the price, and rebuild the case if its original permission assumption fails.

Review enrollment history through the 36-month-rule guide and current moratorium guide. These are separate transaction conditions. A price discount cannot create operating authority, and a high asking price cannot prove a scarce license is transferable.

Track any proposed reserve or price adjustment beside the issue it addresses. Explain whether the matter is already reflected in the earnings forecast or requires another treatment in the deal. Do not describe every uncertainty as the same kind of deduction; collection risk, future costs and missing authority need different responses.

Request a conclusion with a visible line of support

Use the home-health diligence guide to resolve material payment, staffing and operating questions. Keep the payment review, clinical assessment and financial recast connected, with each specialist's scope clear. Missing documentation should have a named reviewer and an identified next step.

Prepare the source schedules through controlled access. A financial exercise does not require public patient records, and an NDA does not settle every disclosure right. Use fictional data for explanations and the authorized process for the target's sensitive evidence.

The valuation discussion should explain how the supported payment model becomes an earnings measure and how that measure supports the selected method. Keep dates, uncertainty and deal conditions visible. The result should be understandable to both parties without suggesting that a national update guarantees a particular price.